title: Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.
authors.affiliation: National Health Laboratory, Ministry of Health and Sports, Yangon, Myanmar.
authors.forename: Thanda
authors.initials: T
authors.lastname: Tun
authors.affiliation: National Tuberculosis Reference Laboratory, Ministry of Health and Sports, Yangon, Myanmar.
authors.forename: Wint Wint
authors.initials: WW
authors.lastname: Nyunt
authors.affiliation: National Tuberculosis Reference Laboratory, Ministry of Health and Sports, Yangon, Myanmar.
authors.forename: Khin Zaw
authors.initials: KZ
authors.lastname: Latt
authors.affiliation: Department of Preventive and Social Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: Ari
authors.initials: A
authors.lastname: Samaranayaka
authors.affiliation: Center for International Health, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
authors.forename: John A
authors.initials: JA
authors.lastname: Crump
authors.affiliation: Department of Microbiology, University of Medicine, Yangon, Myanmar.
authors.forename: Kyi Kyi
authors.initials: KK
authors.lastname: Thinn
authors.affiliation: Department of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand.
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Cook
authors.affiliation: Department of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand. Electronic address: htin.aung@otago.ac.nz.
authors.forename: Htin Lin
authors.initials: HL
authors.lastname: Aung
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism; D002374:Catalase / Q000235:genetics / Q000378:metabolism; D012321:DNA-Directed RNA Polymerases / Q000235:genetics / Q000378:metabolism; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics*; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D015870:Gene Expression; D016680:Genome, Bacterial; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009154:Mutation; D002052:Myanmar; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics* / Q000254:growth & development / Q000378:metabolism; D012008:Recurrence; D012293:Rifampin / Q000627:therapeutic use; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000627:therapeutic use; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D000073336:Whole Genome Sequencing
chemical_list: D000995:Antitubercular Agents; D001426:Bacterial Proteins; C505805:rpoB protein, Mycobacterium tuberculosis; D004977:Ethambutol; D002374:Catalase; C480353:katG protein, Mycobacterium tuberculosis; D012321:DNA-Directed RNA Polymerases; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin